Commentary: Hong Kong HBV Perspective
Hong Kong Perspective: Should Older Age Influence Hepatitis B Treatment Decisions?

Released: December 01, 2022

Expiration: November 30, 2023

George K. K. Lau
George K. K. Lau, MD

Activity

Progress
1
Course Completed

Key Takeaways

  • Defining “older age” is subjective, including in the context of older patients with chronic hepatitis B (CHB).
  • All patients with CHB—regardless of age—should be closely monitored and treated when indicated.
  • Drug treatment for CHB is not costly, but liver cancer is.